Conradt L

Publications (1)0 Total impact

• Article: Disclosure of erlotinib as a multikinase inhibitor in pancreatic ductal adenocarcinoma.

  Conradt L, Godl K, Schaab C, Tebbe A, Eser S, Diersch S, Michalski CW, Kleeff J, Schnieke A, Schmid RM, Saur D, Schneider G.
  Neoplasia. 01/2011; 13:1026-34.